Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Met receptor dynamics and signalling.

D E Hammond1, S Carter, M J Clague

  • 1Physiological Laboratory, University of Liverpool, Liverpool, UK.

Current Topics in Microbiology and Immunology
|January 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What Does Equitable Co-Production Entail? Three Perspectives.

Community science·2026
Same author

Glucagon-like peptide-1 secretion in people with versus without type 2 diabetes: a systematic review and meta-analysis of cross-sectional studies.

Metabolism: clinical and experimental·2022
Same author

Testing a Generalizable Machine Learning Workflow for Aquatic Invasive Species on Rainbow Trout (<i>Oncorhynchus mykiss</i>) in Northwest Montana.

Frontiers in big data·2021
Same author

Differential relationships between parent-child DXA and pQCT bone measures: Results from the Southampton Women's Survey.

Bone·2021
Same author

Patient experiences with hidradenitis suppurativa: the Hidradenitis Patient Experience survey.

Clinical and experimental dermatology·2021
Same author

Changes in fecal microbiota with CFTR modulator therapy: A pilot study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2021
Same journal

Resolution Biology in Soft Tissue Joint Disease.

Current topics in microbiology and immunology·2026
Same journal

A 25+ Year Journey on Yeast-Regulated Cell Death Research.

Current topics in microbiology and immunology·2026
Same journal

Adoptive T-Cell Immunotherapy.

Current topics in microbiology and immunology·2026
Same journal

Resolution Pharmacology Targeting the Melanocortin System.

Current topics in microbiology and immunology·2026
Same journal

Resolution of Skeletal Muscle Inflammation: Role of Specialized Pro-resolving Lipid Mediators in the Recovery from Exercise, Injury, and Disease.

Current topics in microbiology and immunology·2026
Same journal

Epstein-Barr Virus: From the Detection of Sequence Polymorphisms to the Recognition of Viral Strains.

Current topics in microbiology and immunology·2026
See all related articles

Met receptor downregulation is crucial for controlling cell growth and preventing cancer. Defects in Met receptor trafficking and degradation can lead to cell transformation and cancer progression.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • The hepatocyte growth factor (HGF) receptor, Met, regulates invasive growth, proliferation, and morphogenesis, essential for development and regeneration.
  • Dysregulation of Met signaling is implicated in cancer progression and metastasis.
  • Met receptor downregulation via endocytosis and proteasome degradation is a key regulatory mechanism.

Purpose of the Study:

  • To investigate the role of Met receptor trafficking and degradation in cellular transformation.
  • To explore the link between Met endosomal trafficking defects and cancer-associated mutations.

Main Methods:

  • Studied Met receptor downregulation in tissue culture cells upon HGF stimulation.
  • Investigated the involvement of endocytic pathways and proteasome activity in Met degradation.

Related Experiment Videos

  • Analyzed the role of E3-ligase Cbl in Met ubiquitination and downregulation.
  • Examined the functional consequences of a Met receptor mutant defective in Cbl binding.

    • Main Results:

    • Acute HGF stimulation induces Met downregulation through an endocytic mechanism requiring proteasome activity.
    • Perturbing Met trafficking at internalization or early endosome sorting alters signaling.
    • Met ubiquitination by Cbl is essential for receptor downregulation; Cbl-binding deficient mutants transform cells.
    • Naturally occurring Met mutants in cancer may transform cells due to impaired endosomal degradation.

    Conclusions:

    • Met receptor trafficking and degradation are critical for controlling cell growth and preventing oncogenic transformation.
    • Defects in the Met endosomal degradation pathway, particularly involving Cbl, can lead to cellular transformation and contribute to cancer progression.
    • Targeting Met trafficking pathways may offer novel therapeutic strategies for cancers driven by Met dysregulation.